<DOC>
	<DOC>NCT00408135</DOC>
	<brief_summary>The primary objective is to assess the safety of telithromycin (HMR 3647) (20% fine granules) 1g filling sachet in children with infections (Respiratory tract infections, Dermatological infections, Otorhinolaryngological infections, Dentistry/Oral surgery infections). Secondary objectives are to assess the clinical efficacy, bacteriological efficacy and acceptability of telithromycin (20% fine granules) 1g filling sachet in children with infections.</brief_summary>
	<brief_title>Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Outpatients of weight from 7.0 kg. For respiratory tract infections:subjects diagnosed with mild or moderate respiratory tract infection (excluding pneumonia) based on a fever (≥ 38°C) or CReactive Protein positive, clinical symptoms/signs, and laboratory findings. For dermatological infections: subjects diagnosed with mild or moderate dermatological infection in terms of clinical symptoms/signs and laboratory findings. For otorhinolaryngological infections:subjects with purulent / mucopurulent rhinorrhea and postrhinorrhea, subjects diagnosed with mild or moderate otorhinolaryngological infection in terms of clinical symptoms/signs and laboratory findings For dental / oral surgical infections: subjects who have formed obstructive abscess and diagnosed with mild or moderate dental / oral surgical infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Respiratory Tract Infections</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Sinusitis</keyword>
</DOC>